ruxolitinib Articles
Novel therapeutic agents presented at ASH provide hope for patients with hard-to-treat blood disorders
11 December 2012
FDA approves Incytes’ Jakafi, first drug to treat MF; advisory panel backs Pfizer’s Prevnar 13 for adults
17 November 2011
ASCO highlights include GSK’s pazopanib, Novartis’ INC424 and Glivec, B-MS/Otsuka’s Sprycel
6 June 2011
Showing 1-5 of 5 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
